WITHDRAWN

An Observational Study on Treatment Compliance by Children Treated With Growth Hormone

IMprove PAtient Compliance sTudy: An Observational, Cross-sectional Study on Children Treated With Growth Hormone in France

NCT01068639•Novo Nordisk A/S

View on ClinicalTrials.gov

Summary

This study is conducted in Europe. This observational study aims at evaluating compliance with growth hormone treatment in children and identifying factors influencing compliance.

Eligibility

Age

0 - 18 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Child treated for at least one year with growth hormone any growth hormone product
•Followed by the participating paediatrician for at least 1 year.

Exclusion Criteria

•Refusal to participate
•Child and/or parent unable to give consent or fill out the questionnaires
•Child participating in a therapeutic trial

Key Dates

Start Date

February 1, 2010

Primary Completion Date

April 1, 2010

Completion Date

April 1, 2010

Last Updated

June 26, 2014

Conditions

Growth Hormone DisorderGrowth Hormone Deficiency in Children

Interventions

No treatment given

BEHAVIORAL

Special Use-results Surveillance on Long Term Use of Sogroya® in Children With Short Stature Due to Growth Hormone Deficiency Where Epiphysial Discs Are Not Closed

NCT06109935

Growth Hormone Deficiency in Children

View study

COMPLETEDPHASE3

A Research Study in Chinese Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day.

NCT04970654

Growth Hormone Deficiency in Children

View study

COMPLETEDPHASE1

First Human Dose Trial of NNC0195-0092 (Somapacitan) in Healthy Subjects

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 26, 2014Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

NCT01514500

Growth Hormone DisorderAdult Growth Hormone Deficiency+2 more

View study

COMPLETEDPHASE3